共 50 条
- [41] Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trialBMC Psychiatry, 24Laetitia VanderijstFelix HeverAnne BuotCharles DauréJanaïna BenoitCatherine HanakJohannes VeeserMargot MorgièveSalvatore CampanellaCharles KornreichLuc MalletChristophe LeysXavier Noël
- [42] Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trialBMC PSYCHIATRY, 2024, 24 (01)Vanderijst, LaetitiaHever, FelixBuot, AnneDaure, CharlesBenoit, JanainaHanak, CatherineVeeser, JohannesMorgieve, MargotCampanella, SalvatoreKornreich, CharlesMallet, LucLeys, ChristopheNoel, Xavier
- [43] A randomized, double-blind, placebo-controlled, parallel-group 12-week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairmentALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (04)Steiner-Lim, Genevieve Z.Bensoussan, AlanAndrews-Marney, Elana R.Al-Dabbas, Mahmoud A.Cave, Adele E.Chiu, Christine L.Christofides, KaterinaDe Blasio, Frances M.Dewsbury, Lauren S.Fagan, Naomi L.Fogarty, Jack S.Hattom, Lena C.Hohenberg, Mark I.Jafar, DeyyanKaramacoska, DianaLim, Chai K.Liu, JianxunMetri, Najwa-JoelleOxenham, D. VincentRatajec, HollyRoy, NikitaShipton, Danielle G.Varjabedian, DavidChang, Dennis H.
- [45] Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trialSTROKE AND VASCULAR NEUROLOGY, 2024,Zhang, RunhuaLiu, GaifenZhao, XingquanWang, YilongLi, ZixiaoChen, GuofangLiu, BoLing, YunWang, YongjunLi, Shuya
- [46] Effects of Lacticaseibacillus paracasei 327 intake on the intestinal environment in healthy adult Japanese: a randomized, double-blind, placebo-controlled, parallel-group trialFUNCTIONAL FOODS IN HEALTH AND DISEASE, 2024, 14 (03): : 184 - 206Senda-Sugimoto, YoshieMihara, ToshihiroHiguchi, YukiUchiyama, KimikoTakara, TsuyoshiTakahashi, Hajime
- [47] A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosisAMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2016, 17 (5-6) : 426 - 435Shefner, Jeremy M.Wolff, Andrew A.Meng, LisaBian, AmyLee, JacquelineBarragan, DonnaAndrews, Jinsy A.
- [48] Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trialEPILEPSIA OPEN, 2024, 9 (03) : 1007 - 1020Inoue, YushiTiamkao, SomsakZhou, DongCabral-Lim, LeonorLim, Kheng SeangLim, Shih-HuiTsai, Jing-JaneMoseley, BrianWang, LinSun, WeiweiHayakawa, YoshinobuSasamoto, HiroshiSano, TomonobuMcclung, CarrieBass, Almasa
- [49] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trialSCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98Karbalaee, MonireJameie, MelikaAmanollahi, MobinaTaghaviZanjani, FatemeParsaei, MohammadaminBasti, Fatemeh A.Mokhtari, SabaMoradi, KamyarAkhondzadeh, Shahin
- [50] A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)Xiao, ShifuChan, PiuWang, TaoHong, ZhenWang, ShuzhenKuang, WeihongHe, JincaiPan, XiaopingZhou, YuyingJi, YongWang, LuningCheng, YanPeng, YingYe, QinyongWang, XiaopingWu, YunchengQu, QiuminChen, ShengdiLi, ShuhuaChen, WeiXu, JunPeng, DantaoZhao, ZhongxinLi, YanshengZhang, JunjianDu, YifengChen, WeixianFan, DongshengYan, YongLiu, XiaoweiZhang, WeiLuo, BenyanWu, WenyuanShen, LuLiu, ChunfengMao, PeixianWang, QiumeiZhao, QianhuaGuo, QihaoZhou, YongtaoLi, YiJiang, LijunRen, WenweiOuyang, YingjunWang, YanLiu, ShuaiJia, JianjunZhang, NanLiu, ZhonglinHe, Raoli